First deposition using IRIS
During the last week, the collaboration has successfully tested the IRIS (ISOLPHARM Radionuclide Implantation Station) device. The system was coupled and aligned with the SPES Offline beamline in order to perform the first stable beam deposition using this device.
The first test was performed using a stable copper beam. The importance of these experiments is twofold: on the one hand, this allows us to test new apparatus, and on the other hand, it allows for testing the newly developed collection targets and evaluating their recovery performance.